Cargando…
Validation of a Disease-Free Survival Prediction Model Using UBE2C and Clinical Indicators in Breast Cancer Patients
OBJECTIVE: To explore the validation of a disease-free survival (DFS) model for predicting disease progression based on the combination of ubiquitin-conjugating enzyme E2 C (UBE2C) levels and clinical indicators in breast cancer patients. METHODS: We enrolled 121 patients with breast cancer, collect...
Autores principales: | Shen, Jun, Yan, Huanhuan, Yang, Congying, Lin, Haiyue, Li, Fan, Zhou, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149777/ https://www.ncbi.nlm.nih.gov/pubmed/37139241 http://dx.doi.org/10.2147/BCTT.S402109 |
Ejemplares similares
-
Establishment and Validation of a Model for Disease-Free Survival Rate Prediction Using the Combination of microRNA-381 and Clinical Indicators in Patients with Breast Cancer
por: Shen, Jun, et al.
Publicado: (2022) -
Validation of UBE2C protein as a prognostic marker in node-positive breast cancer
por: Loussouarn, D, et al.
Publicado: (2009) -
UBE2S and UBE2C confer a poor prognosis to breast cancer via downregulation of Numb
por: Guo, Yanjing, et al.
Publicado: (2023) -
Contributions of UBE2C and UBE2S to meiotic progression of porcine oocytes
por: FUJIOKA, Yoshie A., et al.
Publicado: (2018) -
UBE2C expression is elevated in hepatoblastoma and correlates with inferior patient survival
por: Nousiainen, Ruth, et al.
Publicado: (2023)